EcoDrugPlus

Dopamine Receptor D1

Ensembl ID : ENSMOCG00000017186
Gene Symbol: DRD1
3 Cross references
261 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSMOCG00000013394
Gene Symbol: DRD2
3 Cross references
219 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSMOCG00000008878
Gene Symbol: DRD3
1 Cross references
206 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSMOCG00000013795
Gene Symbol: DRD4
3 Cross references
246 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSMOCG00000005761
Gene Symbol: DRD5
3 Cross references
186 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSMOCG00000001571
Gene Symbol: ENPP2
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSMOCG00000018917
Gene Symbol: EGLN1
2 Cross references
229 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSMOCG00000004471
Gene Symbol: EGLN2
3 Cross references
190 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSMOCG00000012694
Gene Symbol: EGLN3
3 Cross references
207 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSMOCG00000018764
Gene Symbol: EPAS1
3 Cross references
222 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSMOCG00000019867
Gene Symbol: ECE1
3 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSMOCG00000017745
Gene Symbol: EDNRA
3 Cross references
264 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).